Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,993
Total Claims
$900K
Drug Cost
615
Beneficiaries
$1,463
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+113%
Opioid rate vs peers
4.8% vs 2.2% avg
+4%
Cost per patient vs peers
$1,463 vs $1,411 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.8%
Opioid Rate
525
Opioid Claims
$16K
Opioid Cost
6.3%
Long-Acting Rate
Brand vs Generic
Brand: 1,159 claims · $622K
Generic: 9,781 claims · $275K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 95 | $109K |
| Apixaban | 116 | $105K |
| Rivaroxaban | 68 | $82K |
| Dulaglutide | 33 | $37K |
| Semaglutide | 32 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 38 | $28K |
| Tirzepatide | 25 | $27K |
| Sitagliptin Phosphate | 20 | $21K |
| Budesonide/Formoterol Fumarate | 31 | $16K |
| Mirabegron | 11 | $16K |
| Dapagliflozin Propanediol | 19 | $15K |
| Potassium Chloride | 315 | $15K |
| Pitavastatin Calcium | 32 | $14K |
| Insulin Aspart | 11 | $13K |
| Levothyroxine Sodium | 541 | $11K |
Prescribing Profile
Patient Profile
77
Avg Age
55%
Female
1.24
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About